Incretins, suchas GLP-1, GLP-2, and ghrelin, play an essential role in reducing hepatic steatosis.The anatomical changes promoted by surgery, especially the RYGB, lead to an increasein these substances21. The gene discussed is GCG; the disease is Hepatic steatosis.